Metformin attenuates multiple myeloma cell proliferation and encourages apoptosis by suppressing METTL3-mediated m6A methylation of THRAP3, RBM25, and USP4

References

• Brigle K, Rogers B. Pathobiology and diagnosis of multiple myeloma [J]. Semin Oncol Nurs. 2017;33(3):225–236.
   PubMed Web of Science ®Google Scholar
• Joshua DE, Bryant C, Dix C, et al. Biology and therapy of multiple myeloma [J]. Med J Aust. 2019;210(8):375–380.
   PubMed Web of Science ®Google Scholar
• Van de donk N, Pawlyn C, Yong KL. Multiple myeloma [J]. Lancet. 2021;397(10272):410–427.
   PubMed Web of Science ®Google Scholar
• Mohammed I, Hollenberg MD, Ding H, et al. A critical review of the evidence that metformin is a putative anti-aging drug that enhances healthspan and extends lifespan [J]. Front Endocrinol. 2021;12:718942.
   PubMed Web of Science ®Google Scholar
• Zhang K, Bai P, H Dai, et al. Metformin and risk of cancer among patients with type 2 diabetes mellitus: a systematic review and meta-analysis [J]. Prim Care Diabetes. 2021;15(1):52–58.
   PubMed Web of Science ®Google Scholar
• Mallik R, Ct A. Metformin in cancer [J]. Diabet Res Clin Pract. 2018;143:409–419.
   PubMed Web of Science ®Google Scholar
• Podhorecka M, Ibanez B, Dmoszyńska A. Metformin - its potential anti-cancer and anti-aging effects [J]. Postepy Hig Med Dosw (Online). 2017;71(0):170–175.
   PubMedGoogle Scholar
• Huang F, Xiang Y, Li T, et al. Metformin and MiR-365 synergistically promote the apoptosis of gastric cancer cells via MiR-365-PTEN-AMPK axis [J]. Pathol Res Pract. 2022;230:153740.
   PubMed Web of Science ®Google Scholar
• Yoshida J, Ishikawa T, Endo Y, et al. Metformin inhibits TGF‑β1‑induced epithelial‑mesenchymal transition and liver metastasis of pancreatic cancer cells [J]. Oncol Rep. 2020;44(1):371–381.
   PubMed Web of Science ®Google Scholar
• Lu B, Gs Y, H ZH, et al. Effect of Metformin on Proliferation of Multiple Myeloma Cells] [J. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017;25(4):1097–1100.
   PubMedGoogle Scholar
• Zi FM, Hj S, Y LI, et al. Metformin displays anti-myeloma activity and synergistic effect with dexamethasone in in vitro and in vivo xenograft models [J]. Cancer Lett. 2015;356(2 Pt B):443–453.
   PubMed Web of Science ®Google Scholar
• Grimaldi C, Chiarini F, Tabellini G, et al. AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications [J]. Leukemia. 2012;26(1):91–100.
   PubMed Web of Science ®Google Scholar
• Wang ES, Wetzler M. An oncologist’s perspective on metformin use and acute lymphoblastic leukemia outcomes [J]. J Pharm Pract. 2015;28(1):46–47.
   PubMedGoogle Scholar
• GAO R, Ye M, B LIU, et al. M6a Modification: a Double-Edged Sword in Tumor Development [J]. Front Oncol. 2021;11:679367.
   PubMed Web of Science ®Google Scholar
• Zaccara S, J RR, R JS. Reading, writing and erasing mRNA methylation [J]. Nat Rev Mol Cell Biol. 2019;20(10):608–624.
   PubMed Web of Science ®Google Scholar
• ZHAO BS, Ri A, C HE. Post-transcriptional gene regulation by mRNA modifications [J]. Nat Rev Mol Cell Biol. 2017;18(1):31–42.
   PubMed Web of Science ®Google Scholar
• Sun T, Wu R, Ming L. The role of m6a RNA methylation in cancer [J]. Biomed Pharmacother. 2019;112:108613.
   PubMed Web of Science ®Google Scholar
• Wu X, Ye W, Gong Y. The role of RNA methyltransferase METTL3 in normal and malignant hematopoiesis [J]. Front Oncol. 2022;12:873903.
   PubMed Web of Science ®Google Scholar
• Li D, FU Z, DONG C, et al. Methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit-induced long intergenic non-protein coding RNA 1833 N6-methyladenosine methylation promotes the non-small cell lung cancer progression via regulating heterogeneous nuclear ribonucleoprotein A2/B1 expression [J]. Bioengineered. 2022;13(4):10493–10503.
   PubMed Web of Science ®Google Scholar
• Cui Q, Shi H, Ye P, et al. M(6)a RNA Methylation Regulates the Self-Renewal and Tumorigenesis of Glioblastoma Stem Cells [J]. Cell Rep. 2017;18(11):2622–2634.
   PubMed Web of Science ®Google Scholar
• Che F, Ye X, Wang Y, et al. METTL3 facilitates multiple myeloma tumorigenesis by enhancing YY1 stability and pri-microRNA-27 maturation in m(6)a-dependent manner [J]. Cell Biol Toxicol. 2022. DOI:10.1007/s10565-021-09690-1.
   Web of Science ®Google Scholar
• Cheng L, Zhang X, HY Z, et al. Metformin exhibits antiproliferation activity in breast cancer via miR-483-3p/mettl3/m(6)a/p21 pathway [J]. Oncogenesis. 2021;10(1):7.
   PubMed Web of Science ®Google Scholar
• Gavriatopoulou M, A PS, Ntanasis-stathopoulos I, et al. Metabolic disorders in multiple myeloma [J]. Int J Mol Sci. 2021;22(21):11430.
   PubMed Web of Science ®Google Scholar
• Cowan AJ, J GD, Kwok M, et al. Diagnosis and management of multiple myeloma: a Review [J]. JAMA. 2022;327(5):464–477.
   PubMed Web of Science ®Google Scholar
• MORALES DR, D MA. Metformin in cancer treatment and prevention [J]. Annu Rev Med. 2015;66(1):17–29.
   PubMed Web of Science ®Google Scholar
• Papachristou S, Pd S, PAPANAS N. Reduced Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma in Type 2 Diabetes Mellitus: will Metformin Never Stop Its Pleasant Surprises? J Adv Ther. 2022;39(6):2283–2286.
   PubMed Web of Science ®Google Scholar
• Gao L, Li L, Hu J, et al. Metformin inhibits multiple myeloma serum-induced endothelial cell thrombosis by down-regulating miR-532 [J]. Ann Vasc Surg. 2022;85:347–357.e2.
   PubMed Web of Science ®Google Scholar
• Song Y, Chen S, Xiang W, et al. The mechanism of treatment of multiple myeloma with metformin by way of metabolism [J]. Arch Med Sci. 2021;17(4):1056–1063.
   PubMed Web of Science ®Google Scholar
• Yang T, Liu X, K KS, et al. Decoding DNA methylation in epigenetics of multiple myeloma [J]. Blood Rev. 2022;51:100872.
   PubMed Web of Science ®Google Scholar
• San-miguel J, García-Sanz R, LóPEZ-Pérez R. Analysis of methylation pattern in multiple myeloma [J]. Acta Haematol. 2005;114 Suppl 1(Suppl. 1):23–26.
   PubMedGoogle Scholar
• Hua Z, Wei R, M GUO, et al. YTHDF2 promotes multiple myeloma cell proliferation via STAT5A/MAP2K2/p-ERK axis [J]. Oncogene. 2022;41(10):1482–1491.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Peng H. The role of N(6)-Methyladenosine (m(6)a) Methylation Modifications in Hematological Malignancies [J]. Cancers (Basel). 2022;14(2):332.
   PubMed Web of Science ®Google Scholar
• Yu T, Yao L, Yin H, et al. ALKBH5 promotes multiple myeloma tumorigenicity through inducing m(6)a-demethylation of SAV1 mRNA and myeloma stem cell Phenotype [J]. Int J Biol Sci. 2022;18(6):2235–2248.
   PubMed Web of Science ®Google Scholar
• Zeng C, Huang W, Li Y, et al. Roles of METTL3 in cancer: mechanisms and therapeutic targeting [J]. J Hematol Oncol. 2020;13(1):117.
   PubMed Web of Science ®Google Scholar
• Lin S, Choe J, Du P, et al. The m(6)a Methyltransferase METTL3 promotes translation in human cancer cells [J]. Mol Cell. 2016;62(3):335–345.
   PubMed Web of Science ®Google Scholar
• Li K, Gao S, Ma L, et al. Stimulation of Let-7 Maturation by Metformin Improved the Response to Tyrosine Kinase Inhibitor Therapy in an m6a Dependent Manner [J]. Front Oncol. 2021;11:731561.
   PubMed Web of Science ®Google Scholar
• Zhong T, Men Y, Lu L, et al. Metformin alters DNA methylation genome-wide via the H19/SAHH axis [J]. Oncogene. 2017;36(17):2345–2354.
   PubMed Web of Science ®Google Scholar
• Lu H, Han X, J REN, et al. Metformin attenuates synergic effect of diabetes mellitus and Helicobacter pylori infection on gastric cancer cells proliferation by suppressing PTEN expression [J]. J Cell Mol Med. 2021;25(10):4534–4542.
   PubMed Web of Science ®Google Scholar
• Sorci M, Ianniello Z, Cruciani S, et al. METTL3 regulates WTAP protein homeostasis [J]. Cell Death Dis. 2018;9(8):796.
   PubMedGoogle Scholar
• Kang HJ, Eh J, Kim H, et al. Thrap3 promotes R-loop resolution via interaction with methylated DDX5 [J]. Exp Mol Med. 2021;53(10):1602–1611.
   PubMed Web of Science ®Google Scholar
• Cetani F, Pardi E, Marcocci C. Parathyroid Carcinoma [J]. Front Horm Res. 2019;51:63–76.
   PubMed Web of Science ®Google Scholar
• Ma R, Liu Y, X CHE, et al. Nuclear PD-L1 promotes cell cycle progression of BRAF-mutated colorectal cancer by inhibiting THRAP3 [J]. Cancer Lett. 2022;527:127–139.
   PubMed Web of Science ®Google Scholar
• Zanoni P, Panteloglou G, Othman A, et al. Posttranscriptional regulation of the human LDL Receptor by the U2-Spliceosome [J]. Circ Res. 2022;130(1):80–95.
   PubMed Web of Science ®Google Scholar
• Zhang YF, Wy X, Zhang N, et al. Prognostic alternative splicing regulatory network of RBM25 in hepatocellular carcinoma [J]. Bioengineered. 2021;12(1):1202–1211.
   PubMed Web of Science ®Google Scholar
• Siavoshi A, Taghizadeh M, Dookhe E, et al. Gene expression profiles and pathway enrichment analysis to identification of differentially expressed gene and signaling pathways in epithelial ovarian cancer based on high-throughput RNA-seq data [J]. Genomics. 2022;114(1):161–170.
   PubMed Web of Science ®Google Scholar
• Hu B, Zhang D, Zhao K, et al. Spotlight on USP4: structure, Function, and Regulation [J]. Front Cell Dev Biol. 2021;9:595159.
   PubMed Web of Science ®Google Scholar
• Mattiroli F, PENENGO L. Histone ubiquitination: an integrative signaling platform in genome stability [J]. Trends Genet. 2021;37(6):566–581.
   PubMed Web of Science ®Google Scholar
• Zhu J, Luo Z, Y PAN, et al. H19/mir-148a/usp4 axis facilitates liver fibrosis by enhancing TGF-β signaling in both hepatic stellate cells and hepatocytes [J]. J Cell Physiol. 2019;234(6):9698–9710.
   PubMed Web of Science ®Google Scholar
• Wang L, Zhao W, Zhang M, et al. USP4 positively regulates RIG-I-mediated antiviral response through deubiquitination and stabilization of RIG-I [J]. J Virol. 2013;87(8):4507–4515.
   PubMed Web of Science ®Google Scholar
• HUANG Y, WANG Y, WANG X, et al. The Effects of the transforming growth factor-β1 (TGF-β1) Signaling Pathway on Cell Proliferation and Cell migration are mediated by ubiquitin specific protease 4 (USP4) in hypertrophic scar tissue and primary fibroblast cultures [J]. Med Sci Monit. 2020;26:e920736.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhou L, Lu J, et al. USP4 function and multifaceted roles in cancer: a possible and potential therapeutic target [J]. Cancer Cell Int. 2020;20(1):298.
   PubMed Web of Science ®Google Scholar
• Guo W, Ma J, Pei T, et al. Up-regulated deubiquitinase USP4 plays an oncogenic role in melanoma [J]. J Cell Mol Med. 2018;22(5):2944–2954.
   PubMed Web of Science ®Google Scholar
• Xing C, Lx X, Gp D, et al. Ubiquitin-Specific Protease 4-Mediated Deubiquitination and Stabilization of PRL-3 is Required for Potentiating Colorectal Oncogenesis [J]. Cancer Res. 2016;76(1):83–95.
   PubMed Web of Science ®Google Scholar
• Glage S, La L, Mertens P, et al. Evaluation of biocompatibility and anti-glioma efficacy of doxorubicin and irinotecan drug-eluting bead suspensions in alginate [J]. Clin Transl Oncol. 2012;14(1):50–59.
   PubMed Web of Science ®Google Scholar
• Kumari R, MM M, Lievonen J, et al. Prognostic significance of esterase gene expression in multiple myeloma [J]. Br J Cancer. 2021;124(8):1428–1436.
   PubMed Web of Science ®Google Scholar
• Chen Y, Pan C, Wang X, et al. Silencing of METTL3 effectively hinders invasion and metastasis of prostate cancer cells [J]. Theranostics. 2021;11(16):7640–7657.
   PubMed Web of Science ®Google Scholar